Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Seek medical help if serious symptoms occur
For most people, gastrointestinal side effects peak within the first few weeks of treatment and gradually improve over 4 to 6 weeks
To view a copy of this licence, visit About this article Cite this article Cankat, S., Demael, M.U
Depending on your situation, other medications may be appropriate: Tirzepatide (brand name Mounjaro or Zepbound) is a dual GLP-1/GIP receptor agonist that has shown even greater weight loss in clinical trials
FDA-Approved Indications for GLP-1 and GIP/GLP-1 Receptor Agonists as of 2026
Sources 2013 - 2026 Al Muhsineen Limited
US$ 26.24
US$ 28.56
US$ 26.13
US$ 20.63
US$ 25.45
